{"title":"Trends, disparities, and multilevel interventions: A global review of HPV vaccination among university students.","authors":"Yunjun Yan, Shuang Guan, Wei Chen, Junli Shi, Ruoyu Chao, Jing Fang, Chunhui Zheng, Zhen Yang","doi":"10.1080/21645515.2026.2667395","DOIUrl":null,"url":null,"abstract":"<p><p>Human papillomavirus (HPV) vaccination is a critical yet underutilized strategy for preventing HPV-related cancers in young adults. University students represent a key demographic for catch-up vaccination owing to their risk profile and transitional healthcare access. This review synthesized data from January 2015 to February 2026 to examine the trends, disparities, and determinants of HPV vaccine uptake in this population. Vaccination rates remain suboptimal worldwide, with pronounced disparities across sex, race/ethnicity, socioeconomic status, and geographic regions. Key barriers operate at multiple levels: individual (knowledge gaps, low perceived risk, hesitancy), interpersonal (lack of provider recommendations), and structural (cost, healthcare access). Promising evidence-based interventions include proactive campus health services, digital campaigns tailored to Generation Z, healthcare provider recommendations, and supportive policies. An integrated socioecological approach coordinating strategies across these levels is essential. This review highlights the urgent need for equity-focused multichannel interventions and policies to improve HPV vaccination coverage among university students worldwide.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"22 1","pages":"2667395"},"PeriodicalIF":4.2000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13155025/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2026.2667395","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Human papillomavirus (HPV) vaccination is a critical yet underutilized strategy for preventing HPV-related cancers in young adults. University students represent a key demographic for catch-up vaccination owing to their risk profile and transitional healthcare access. This review synthesized data from January 2015 to February 2026 to examine the trends, disparities, and determinants of HPV vaccine uptake in this population. Vaccination rates remain suboptimal worldwide, with pronounced disparities across sex, race/ethnicity, socioeconomic status, and geographic regions. Key barriers operate at multiple levels: individual (knowledge gaps, low perceived risk, hesitancy), interpersonal (lack of provider recommendations), and structural (cost, healthcare access). Promising evidence-based interventions include proactive campus health services, digital campaigns tailored to Generation Z, healthcare provider recommendations, and supportive policies. An integrated socioecological approach coordinating strategies across these levels is essential. This review highlights the urgent need for equity-focused multichannel interventions and policies to improve HPV vaccination coverage among university students worldwide.
期刊介绍:
(formerly Human Vaccines; issn 1554-8619)
Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.
Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.